Literature DB >> 28285426

Fetal growth restriction: current knowledge.

Luciano Marcondes Machado Nardozza1, Ana Carolina Rabachini Caetano1, Ana Cristina Perez Zamarian1, Jaqueline Brandão Mazzola1, Carolina Pacheco Silva1, Vivian Macedo Gomes Marçal1, Thalita Frutuoso Lobo1, Alberto Borges Peixoto1,2, Edward Araujo Júnior3.   

Abstract

BACKGROUND: Fetal growth restriction (FGR) is a condition that affects 5-10% of pregnancies and is the second most common cause of perinatal mortality. This review presents the most recent knowledge on FGR and focuses on the etiology, classification, prediction, diagnosis, and management of the condition, as well as on its neurological complications.
METHODS: The Pubmed, SCOPUS, and Embase databases were searched using the term "fetal growth restriction".
RESULTS: Fetal growth restriction (FGR) may be classified as early or late depending on the time of diagnosis. Early FGR (<32 weeks) is associated with substantial alterations in placental implantation with elevated hypoxia, which requires cardiovascular adaptation. Perinatal morbidity and mortality rates are high. Late FGR (≥32 weeks) presents with slight deficiencies in placentation, which leads to mild hypoxia and requires little cardiovascular adaptation. Perinatal morbidity and mortality rates are lower. The diagnosis of FGR may be clinical; however, an arterial and venous Doppler ultrasound examination is essential for diagnosis and follow-up. There are currently no treatments to control FGR; the time at which pregnancy is interrupted is of vital importance for protecting both the mother and fetus.
CONCLUSION: Early diagnosis of FGR is very important, because it enables the identification of the etiology of the condition and adequate monitoring of the fetal status, thereby minimizing risks of premature birth and intrauterine hypoxia.

Entities:  

Keywords:  Doppler; Fetal growth restriction; Management; Neurological development; Placental insufficiency; Prediction

Mesh:

Year:  2017        PMID: 28285426     DOI: 10.1007/s00404-017-4341-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  91 in total

1.  Use of a human embryonic stem cell model to discover GABRP, WFDC2, VTCN1 and ACTC1 as markers of early first trimester human trophoblast.

Authors:  Rowan M Karvas; Samuel McInturf; Jie Zhou; Toshihiko Ezashi; Danny J Schust; R Michael Roberts; Laura C Schulz
Journal:  Mol Hum Reprod       Date:  2020-06-01       Impact factor: 4.025

Review 2.  Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development.

Authors:  Laura J Yockey; Akiko Iwasaki
Journal:  Immunity       Date:  2018-09-18       Impact factor: 31.745

3.  A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis.

Authors:  Masahiro Tsuji; Jacques-Olivier Coq; Yuko Ogawa; Yumi Yamamoto; Makiko Ohshima
Journal:  J Vis Exp       Date:  2018-01-07       Impact factor: 1.355

4.  Association of Intrauterine Growth Restriction and Small for Gestational Age Status With Childhood Cognitive Outcomes: A Systematic Review and Meta-analysis.

Authors:  Chiara Sacchi; Claudia Marino; Chiara Nosarti; Alessio Vieno; Silvia Visentin; Alessandra Simonelli
Journal:  JAMA Pediatr       Date:  2020-08-01       Impact factor: 16.193

5.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

6.  Ozone Exposure During Implantation Increases Serum Bioactivity in HTR-8/SVneo Trophoblasts.

Authors:  Colette N Miller; Erica J Stewart; Samantha J Snow; Wanda C Williams; Judy H Richards; Leslie C Thompson; Mette C Schladweiler; Aimen K Farraj; Urmila P Kodavanti; Janice A Dye
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

7.  Melatonin 1A and 1B Receptors' Expression Decreases in the Placenta of Women with Fetal Growth Restriction.

Authors:  Andrii M Berbets; Igor S Davydenko; Adrian M Barbe; Dmytro H Konkov; Olena M Albota; Oleksandr M Yuzko
Journal:  Reprod Sci       Date:  2020-08-17       Impact factor: 3.060

8.  Long-term high altitude hypoxia during gestation suppresses large conductance Ca2+ -activated K+ channel function in uterine arteries: a causal role for microRNA-210.

Authors:  Xiang-Qun Hu; Chiranjib Dasgupta; Jeffery Xiao; Shumei Yang; Lubo Zhang
Journal:  J Physiol       Date:  2018-07-01       Impact factor: 5.182

9.  The role and mechanism of asymmetric dimethylarginine in fetal growth restriction via interference with endothelial function and angiogenesis.

Authors:  Yan Dai; Jun Zhang; Rong Liu; Na Xu; Song-Biao Yan; Yi Chen; Tian-He Li
Journal:  J Assist Reprod Genet       Date:  2020-03-25       Impact factor: 3.412

10.  MiR-590-3p and its targets VEGF, PIGF, and MMP9 in early, middle, and late pregnancy: their longitudinal changes and correlations with risk of fetal growth restriction.

Authors:  Jindan Pei; Yan Li; Zhihong Min; Qi Dong; Jiali Ruan; Juan Wu; Xiaolin Hua
Journal:  Ir J Med Sci       Date:  2021-06-22       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.